Latest stories on MLYS
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Mineralys: Why I'm Making Stock A Buy Ahead Of Hypertension Approval Decision
Seeking Alpha67 · bullishanalyst
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
Business Insider56 · neutralgeneral
Mineralys (MLYS) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Mineralys Therapeutics price target lowered to $49 from $51 at BofA
The Fly34 · bearishanalyst
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Mineralys outlines launch readiness ahead of December 22, 2026 PDUFA, with cash runway into 2028
Seeking Alpha63 · neutralproduct/pr
Mineralys Therapeutics, Inc. (MLYS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Mineralys Therapeutics, Inc. Q2 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings
Mineralys Therapeutics Q2 Earnings Call Highlights
Yahoo Finance48 · neutralearnings
Why is Mineralys Therapeutics stock sliding today?
Investing.com Markets42 · neutralgeneral
Mineralys Therapeutics Appoints New Chief Medical Officer
TipRanks55 · neutralgeneral
Mineralys Therapeutics GAAP EPS of -$2.85 misses by $2.30
Seeking Alpha34 · bearishearnings
Mineralys Therapeutics, Inc. (MLYS) files 8-K
SEC 8-K50 · neutralgeneral
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Business Insider56 · neutralearnings
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire56 · neutralearnings
Mineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026
Business Insider50 · neutralgeneral
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date
Yahoo Finance63 · neutralgeneral
What to Know About This Mineralys Insider Sale Before a December FDA Date
Yahoo Top48 · neutralgeneral
A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date
The Motley Fool73 · bullishgeneral
What to Know About This Mineralys Insider Sale Before a December FDA Date
The Motley Fool48 · neutralgeneral
A $500 Million Funding Deal Could Make Mineralys Therapeutics (MLYS) Stock A Multibagger
Yahoo Finance73 · bullishanalyst
Is Mineralys Therapeutics, Inc. (MLYS) Stock a Biotech Opportunity With Lorundrostat’s Expanding Cardiovascular Potential?
Yahoo Finance57 · neutralanalyst